Findings From SITC 2022
Nov 18, 2022•18 min•Ep. 166
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
"
On this episode, we're hearing from three authors of high-impact research that was presented at the recent Annual Meeting of the Society for Immunotherapy of Cancer, or SITC. Their studies focused on immune checkpoint inhibitors for patients living with HIV and cancer, T-cell receptor T-cell therapy for patients with solid tumors, and radiation boosts plus pembrolizumab in patients with triple-negative breast cancer.
To listen to more podcasts from ASCO, visit asco.org/podcasts.
"
For the best experience, listen in Metacast app for iOS or Android